Thasneem, K.M. et al. 2020. SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease. Journal of Drug Delivery and Therapeutics. 10, 6 (Nov. 2020), 203–206. DOI:https://doi.org/10.22270/jddt.v10i6.4532.